Literature DB >> 25502425

Next-generation sequencing for hereditary breast and gynecologic cancer risk assessment.

Allison W Kurian1, Kerry E Kingham, James M Ford.   

Abstract

PURPOSE OF REVIEW: To summarize advances in next-generation sequencing and their application to breast and gynecologic cancer risk assessment. RECENT
FINDINGS: Next-generation sequencing panels of 6-112 cancer-associated genes are increasingly used in patient care. Studies report a 4-16% prevalence of mutations other than BRCA1/2 among patients who meet evidence-based practice guidelines for BRCA1/2 testing, with a high rate (15-88%) of uninterpretable variants of uncertain significance. Despite uncertainty about results interpretation and communication, there is early evidence of a benefit from multiple-gene sequencing panels for appropriately selected patients.
SUMMARY: Multiple-gene sequencing panels appear highly promising for the assessment of breast and gynecologic cancer risk, and they may usefully be administered in the context of cancer genetics expertise and/or clinical research protocols.

Entities:  

Mesh:

Year:  2015        PMID: 25502425     DOI: 10.1097/GCO.0000000000000141

Source DB:  PubMed          Journal:  Curr Opin Obstet Gynecol        ISSN: 1040-872X            Impact factor:   1.927


  16 in total

Review 1.  Population genetic testing for cancer susceptibility: founder mutations to genomes.

Authors:  William D Foulkes; Bartha Maria Knoppers; Clare Turnbull
Journal:  Nat Rev Clin Oncol       Date:  2015-10-20       Impact factor: 66.675

Review 2.  Ovarian Cancer Prevention in High-risk Women.

Authors:  Sarah M Temkin; Jennifer Bergstrom; Goli Samimi; Lori Minasian
Journal:  Clin Obstet Gynecol       Date:  2017-12       Impact factor: 2.190

3.  Payer Coverage for Hereditary Cancer Panels: Barriers, Opportunities, and Implications for the Precision Medicine Initiative.

Authors:  Julia R Trosman; Christine B Weldon; Michael P Douglas; Allison W Kurian; R Kate Kelley; Patricia A Deverka; Kathryn A Phillips
Journal:  J Natl Compr Canc Netw       Date:  2017-02-10       Impact factor: 11.908

4.  Traceback: A Proposed Framework to Increase Identification and Genetic Counseling of BRCA1 and BRCA2 Mutation Carriers Through Family-Based Outreach.

Authors:  Goli Samimi; Marcus Q Bernardini; Lawrence C Brody; Charlisse F Caga-Anan; Ian G Campbell; Georgia Chenevix-Trench; Fergus J Couch; Michael Dean; Joanne A de Hullu; Susan M Domchek; Ronny Drapkin; Heather Spencer Feigelson; Michael Friedlander; Mia M Gaudet; Marline G Harmsen; Karen Hurley; Paul A James; Janice S Kwon; Felicitas Lacbawan; Stephanie Lheureux; Phuong L Mai; Leah E Mechanic; Lori M Minasian; Evan R Myers; Mark E Robson; Susan J Ramus; Lisa F Rezende; Patricia A Shaw; Thomas P Slavin; Elizabeth M Swisher; Masataka Takenaka; David D Bowtell; Mark E Sherman
Journal:  J Clin Oncol       Date:  2017-04-11       Impact factor: 44.544

Review 5.  The Changing Landscape of Genetic Testing for Inherited Breast Cancer Predisposition.

Authors:  Anosheh Afghahi; Allison W Kurian
Journal:  Curr Treat Options Oncol       Date:  2017-05

6.  Availability and payer coverage of BRCA1/2 tests and gene panels.

Authors:  Elizabeth Clain; Julia R Trosman; Michael P Douglas; Christine B Weldon; Kathryn A Phillips
Journal:  Nat Biotechnol       Date:  2015-09       Impact factor: 54.908

7.  Genetic Testing and Clinical Management Practices for Variants in Non-BRCA1/2 Breast (and Breast/Ovarian) Cancer Susceptibility Genes: An International Survey by the Evidence-Based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) Clinical Working Group.

Authors:  Sarah M Nielsen; Diana M Eccles; Iris L Romero; Fahd Al-Mulla; Judith Balmaña; Michela Biancolella; Rien Bslok; Maria Adelaide Caligo; Mariarosaria Calvello; Gabriele Lorenzo Capone; Pietro Cavalli; T L Chris Chan; Kathleen B M Claes; Laura Cortesi; Fergus J Couch; Miguel de la Hoya; Simona De Toffol; Orland Diez; Susan M Domchek; Ros Eeles; Anna Efremidis; Florentia Fostira; David Goldgar; Andreas Hadjisavvas; Thomas V O Hansen; Akira Hirasawa; Claude Houdayer; Petra Kleiblova; Sophie Krieger; Conxi Lázaro; Maria Loizidou; Siranoush Manoukian; Arjen R Mensenkamp; Setareh Moghadasi; Alvaro N Monteiro; Luigi Mori; April Morrow; Nadia Naldi; Henriette R Nielsen; Olufunmilayo I Olopade; Nicholas S Pachter; Edenir I Palmero; Inge S Pedersen; Maria Piane; Marianna Puzzo; Mark Robson; Maria Rossing; Maria Christina Sini; Angela Solano; Jana Soukupova; Gianluca Tedaldi; Manuel Teixeira; Mads Thomassen; Maria Grazia Tibiletti; Amanda Toland; Therese Törngren; Erica Vaccari; Liliana Varesco; Ana Vega; Yvonne Wallis; Barbara Wappenschmidt; Jeffrey Weitzel; Amanda B Spurdle; Arcangela De Nicolo; Encarna B Gómez-García
Journal:  JCO Precis Oncol       Date:  2018-10-26

8.  Management of Incidental Findings in the Era of Next-generation Sequencing.

Authors:  Heather L Blackburn; Bradley Schroeder; Clesson Turner; Craig D Shriver; Darrell L Ellsworth; Rachel E Ellsworth
Journal:  Curr Genomics       Date:  2015-06       Impact factor: 2.236

9.  Benchmarking of Whole Exome Sequencing and Ad Hoc Designed Panels for Genetic Testing of Hereditary Cancer.

Authors:  Lídia Feliubadaló; Raúl Tonda; Mireia Gausachs; Jean-Rémi Trotta; Elisabeth Castellanos; Adriana López-Doriga; Àlex Teulé; Eva Tornero; Jesús Del Valle; Bernat Gel; Marta Gut; Marta Pineda; Sara González; Mireia Menéndez; Matilde Navarro; Gabriel Capellá; Ivo Gut; Eduard Serra; Joan Brunet; Sergi Beltran; Conxi Lázaro
Journal:  Sci Rep       Date:  2017-01-04       Impact factor: 4.379

Review 10.  Multi-Gene Testing Overview with a Clinical Perspective in Metastatic Triple-Negative Breast Cancer.

Authors:  Martina Dameri; Lorenzo Ferrando; Gabriella Cirmena; Claudio Vernieri; Giancarlo Pruneri; Alberto Ballestrero; Gabriele Zoppoli
Journal:  Int J Mol Sci       Date:  2021-07-01       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.